Title : Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.

Pub. Date : 2016 Feb

PMID : 26817709






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-beta1/Smad and GRAP pathways. ruboxistaurin transforming growth factor, beta 1 Rattus norvegicus
2 OBJECTIVE: To investigate whether ruboxistaurin (a selective PKC-beta inhibitor) mediates renoprotective effect via interference with TGF-beta1/Smad-GRAP cross-signalling. ruboxistaurin transforming growth factor, beta 1 Rattus norvegicus
3 A significant up-regulation of TGF-beta1, Smad2 and Smad3 mRNA expression was observed in diabetic rats, which was alleviated by administration of ruboxistaurin. ruboxistaurin transforming growth factor, beta 1 Rattus norvegicus
4 Furthermore, immunoblotting showed a significant improvement in protein levels of TGF-beta1 (P < 0.01), Smad2/3 (P < 0.01) and p-Smad3 (P < 0.001) in diabetic rats treated with ruboxistaurin compared to untreated. ruboxistaurin transforming growth factor, beta 1 Rattus norvegicus
5 CONCLUSION: These data suggest that the renoprotective effect of ruboxistaurin is possibly due to down-regulation of TGF-beta1/Smad pathway and normalization of GRAP protein expression. ruboxistaurin transforming growth factor, beta 1 Rattus norvegicus